Latest News about AZN
Recent news which mentions AZN
This Could Be Another Blockbuster Indication for AstraZeneca
January 17, 2022
Tickers
AZN
From Motley Fool
The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
January 16, 2022
From Benzinga
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
From Motley Fool
Novavax Still Has Not Received an FDA EUA as the Market Waits
January 14, 2022
From InvestorPlace
1 Top Dividend Stock to Buy and Hold in 2022 and Beyond
January 13, 2022
From Motley Fool
The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact
January 13, 2022
From Benzinga
From Benzinga
AstraZeneca's COVID-19 Vaccine Booster Against Omicron, Delta - New Data Supports Use
January 13, 2022
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
From Benzinga
Scorpion Therapeutics, AstraZeneca Ink Precision Medicines Pact For Hard-To-Target Cancer Proteins
January 13, 2022
From Benzinga
Which Vaccine Stocks Will Make You a Fortune in 2022?
January 12, 2022
From Motley Fool
From MarketWatch
From Benzinga
3 Big FDA Approvals to Watch For in Q1 2022
January 09, 2022
From Motley Fool
2 Growth Stocks That Are Also Generating Billions in Free Cash
January 08, 2022
From Motley Fool
7 Pharmaceutical Stocks That Could Make You Rich
January 06, 2022
From InvestorPlace
Cannabis Movers & Shakers: Aurora Bolsters Management, Curaleaf Names New Pres, Verano & Avicanna's New Appointments
January 04, 2022
From Benzinga
Acasti Pharma: Bouncing Back With a New Drug Pipeline
January 04, 2022
From Benzinga
From Benzinga
GNPX Stock: 5 Things to Know as Genprex Rockets Higher
January 03, 2022
From InvestorPlace
Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
January 03, 2022
From Benzinga
Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact
January 03, 2022
From Benzinga
The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week
January 02, 2022
From Benzinga
These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?
January 01, 2022
From Motley Fool
Could AstraZeneca Help You Retire a Millionaire?
January 01, 2022
From Motley Fool
3 COVID Stocks to Fight Omicron
December 23, 2021
From Motley Fool
From Benzinga
FDA adds Merck antiviral to COVID-19 tool kit for high-risk adults above 18, amid flurry of positive news on boosters
December 23, 2021
From MarketWatch
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
December 23, 2021
From Benzinga
Oil edges higher after ending at nearly 1-month high
December 23, 2021
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.